Diet and Exercise

The role of probiotics in nutritional health: probiotics as nutribiotics

Biomarkers, Diet and Exercise, Gut Dysbiosis, Gut Microbiota, Gut Permeability / Leaky Gut, Gut-Brain axis, Parkinson's Disease, Pre-PD, Probiotics, Prebiotics and Symbiotics /

The gut microbiota has gained importance through the years due to its significant influences on the maintenance of human health. A wide variety of microorganisms shape this gut microbiota, which preserves health with the modulation of the immune system, enhancement of the nutrients absorption, or the protection against pathogens’ colonization. The disruption of this microenvironment […]

The role of probiotics in nutritional health: probiotics as nutribiotics Read More »

The Emerging Scenario of the Gut–Brain Axis: The Therapeutic Actions of the New Actor Kefir against Neurodegenerative Diseases

Anti-oxidants, Constipation, Diet and Exercise, Gut Microbiota, Gut Permeability / Leaky Gut, Gut-Brain axis, Metabolites, Parkinson's Disease, Pre-PD, Probiotics, Prebiotics and Symbiotics /

The fact that millions of people worldwide suffer from Alzheimer’s disease (AD) orParkinson’s disease (PD), the two most prevalent neurodegenerative diseases (NDs), has beena permanent challenge to science. New tools were developed over the past two decades andwere immediately incorporated into routines in many laboratories, but the most valuable scientificcontribution was the “waking up” of

The Emerging Scenario of the Gut–Brain Axis: The Therapeutic Actions of the New Actor Kefir against Neurodegenerative Diseases Read More »

Diet Quality and Risk of Parkinson’s Disease: The Rotterdam Study

Diet and Exercise, Parkinson's Disease, Pre-PD /

The Mediterranean diet has been associated with the risk of Parkinson’s disease (PD),but limited research has been performed on other dietary patterns. We studied the relationshipbetween overall diet quality and PD risk in the general population. We included 9414 participantsfrom the Rotterdam Study, a prospective population-based study in the Netherlands. Diet wasdefined using a Dutch

Diet Quality and Risk of Parkinson’s Disease: The Rotterdam Study Read More »

Metabolic Strategies in Healthcare: A New Era

Diet and Exercise, Fasting, Mitochondria /

Modern healthcare systems are founded on a disease-centric paradigm, which has conferred manynotable successes against infectious disorders in the past. However, today’s leading causes of death are dominatedby non-infectious “lifestyle” disorders, broadly represented by the metabolic syndrome, atherosclerosis, cancer,and neurodegeneration. Our disease-centric paradigm regards these disorders as distinct disease processes,caused and driven by disease targets

Metabolic Strategies in Healthcare: A New Era Read More »

Microbiota in Health and Disease—Potential Clinical Applications

A-Synuclein, Butyrate, Diet and Exercise, Gut Microbiota, Gut-Brain axis, Parkinson's Disease, Pre-PD, Short Chain Fatty Acids, Vagal Nerve /

: Within the last two decades tremendous efforts in biomedicine have been undertaken tounderstand the interplay of commensal bacteria living in and on our human body with our ownhuman physiology. It became clear that (1) a high diversity especially of the microbial communitiesin the gut are important to preserve health and that (2) certain bacteria

Microbiota in Health and Disease—Potential Clinical Applications Read More »

Treating chronic diseases by regulating the gut microbiota

Butyrate, Diet and Exercise, Gut Dysbiosis, Gut Microbiota, Short Chain Fatty Acids, Vitamins / Supplements / Nutraceuticals /

Chronic diseases encompass a wide range of illnesses, ranging from cardiovascular and cerebrovascular diseases, metabolic syndromes to degenerative neurological disorders. Chronic diseases are responsible for most observed morbidity and mortality in the developed countries as well as in some developing countries. The gut microbiota and its metabolites have been associated with the onset and development

Treating chronic diseases by regulating the gut microbiota Read More »

Interactions between gut microbiota and berberine, a necessary procedure to understand the mechanisms of berberine

Diet and Exercise, Gut Dysbiosis, Gut Microbiota, Vitamins / Supplements / Nutraceuticals /

Berberine (BBR), an isoquinoline alkaloid, has been found in many plants, such as Coptis chinensis Franch. and Phellodendron chinense Schneid. Although BBR has a wide spectrum of pharmacological effects, its oral bioavailability is extremely low. In recent years, gut microbiota has emerged as a cynosure to understand the mechanisms of action of herbal compounds. Numerous studies have demonstrated that,

Interactions between gut microbiota and berberine, a necessary procedure to understand the mechanisms of berberine Read More »

Parkinson’s disease: the nutrition perspective

Diet and Exercise, Parkinson's Disease, Pre-PD /

Parkinson‟s disease (PD) is the second most common neurodegenerative disease after Alzheimer‟sdisease and affects ~1% of the population over the age of 60 years in industrialised countries. Theaim of this review is to examine nutrition in PD across three domains: dietary intake and thedevelopment of PD; whole body metabolism in PD; and the effects of

Parkinson’s disease: the nutrition perspective Read More »

Recent aspects of ketogenic diet in neurological disorders

Diet and Exercise /

The ketogenic diet (KD) is a high-fat, low-carbohydrate diet, in which fat is used as the primary energy sourcethrough the production of ketone bodies (KBs) in place of glucose. The KD was formally introduced in 1921 tomimic the biochemical changes associated with fasting and gained recognition as a potent treatment for pediatricepilepsy in the mid-1990s.

Recent aspects of ketogenic diet in neurological disorders Read More »

Parkinson’s disease patients’ short chain fatty acids production capacity after in vitro fecal fiber fermentation

Butyrate, Diet and Exercise, Gut Permeability / Leaky Gut, Parkinson's Disease, Probiotics, Prebiotics and Symbiotics, Short Chain Fatty Acids /

Short-chain fatty acid production was analyzed by headspace solid-phase micro-extraction gas chromatography-mass spectrometry. Clostridium coccoides and C. leptum were quantified through 16S-rRNA gene-targeted group-specific qPCR. Factors influencing short-chain fatty acid production were investigated using linear mixed models. After fiber fermentation, butyrate concentration varied between 25.6 ± 16.5 µmol/g and 203.8 ± 91.9 µmol/g for Parkinson’s patients and between 52.7 ± 13.0 µmol/g and 229.5 ± 42.8 µmol/g for controls. Inulin had

Parkinson’s disease patients’ short chain fatty acids production capacity after in vitro fecal fiber fermentation Read More »